Literature DB >> 32336524

Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.

C Pedrazzani1, C Conti2, G A Zamboni3, M Chincarini3, G Turri2, A Valdegamberi2, A Guglielmi2.   

Abstract

BACKGROUND & AIMS: Studies analyzing the impact of visceral fat excess on surgical outcomes after resection for colorectal cancer (CRC) have yielded conflicting results. Visceral obesity (VO) and sarcobesity (SO) have been recently addressed as risk factors for poor short-term results while no data are available for recovery goals after surgery. No data are available on the protective effect of ERAS in VO and SO patients. The aim of this study was to assess clinical implications of computed tomography (CT) assessed VO and SO on surgical and recovery outcomes after minimally invasive resection for CRC before and after ERAS protocol implementation.
METHODS: Visceral adipose tissue (VAT) and skeletal muscle area (SMA) were retrospectively assessed using pre-operative CT studies of 261 patients who underwent laparoscopic resection for CRC between January 2012 and April 2019; ERAS protocol was adopted in 160 patients operated on after March 2014. Patients' surgical and recovery outcomes were compared according to BMI categories, VO and SO which was defined using the VAT/SMA ratio (Sarcobesity Index). Predictive factors for poor surgical and recovery outcomes were evaluated by univariate and multivariate analyses.
RESULTS: Of the 261 patients, 12.6% were BMI obese while 68.6% presented visceral obesity. BMI was not associated to any of the outcomes considered. No differences in intra-operative results were found except for a lower number of retrieved lymph nodes both in VO and SO patients. While VO showed no impact on post-operative course, SO resulted an independent risk factor for cardiac complications and prolonged post-operative ileus (PPOI) at logistic regression analysis. Furthermore, sarcobese patients showed delayed recovery after surgery. Patients enrolled in the ERAS protocol showed improved recovery outcomes for both VO and SO groups, although ERAS did not result to be a protective factor for cardiac complications and PPOI.
CONCLUSIONS: A high Sarcobesity Index is a risk factor for developing cardiac complications and PPOI after laparoscopic resection for CRC. A reduced number of lymph nodes retrieved is associated to VO and SO. These conditions should then be considered in clinical practice for the risk of down staging the N stage. Effect of VO and SO on recovery items after surgery should be further investigated. ERAS protocol application should be implemented to improve recovery outcomes in VO and SO patients undergoing laparoscopic colorectal resection.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Colorectal; Laparoscopy; Sarcobesity; Visceral obesity

Year:  2020        PMID: 32336524     DOI: 10.1016/j.clnu.2020.04.004

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  4 in total

1.  Impact of Excess Body Weight on Postsurgical Complications.

Authors:  Lars Plassmeier; Mohammed K Hankir; Florian Seyfried
Journal:  Visc Med       Date:  2021-08-02

2.  Visceral obesity enhances inflammatory response after laparoscopic colorectal resection.

Authors:  Cristian Conti; Corrado Pedrazzani; Giulia Turri; Gabriele Gecchele; Alessandro Valdegamberi; Andrea Ruzzenente; Giulia A Zamboni; Giuseppe Lippi; Alfredo Guglielmi
Journal:  Int J Clin Pract       Date:  2021-09-15       Impact factor: 3.149

3.  Sarcopenic obesity and therapeutic outcomes in gastrointestinal surgical oncology: A meta-analysis.

Authors:  Peiyu Wang; Shaodong Wang; Yi Ma; Haoran Li; Zheng Liu; Guihu Lin; Xiao Li; Fan Yang; Mantang Qiu
Journal:  Front Nutr       Date:  2022-07-22

4.  The Association Between Visceral Obesity and Postoperative Outcomes in Elderly Patients With Colorectal Cancer.

Authors:  Qiantong Dong; Haonan Song; Weizhe Chen; Wenbin Wang; Xiaojiao Ruan; Tingting Xie; Dongdong Huang; Xiaolei Chen; Chungen Xing
Journal:  Front Surg       Date:  2022-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.